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Abstract. Background: Commercially available ELISA kits
are popular among investigators that quantify faecal
corticosterone or cortisol metabolites (FCM) for stress
assessment in animals. However, in faeces, these assays
mainly detect immunoreactive glucocorticoid metabolites.
Since different assays contain antibodies of different origin,
the detection level and cross-reactivity towards different
metabolites and other steroids differ considerably between
assays. Thus, the validity of one assay for FCM quantification
in stress assessment is not necessarily the same for another
assay. Materials and Methods: The present study was
designed to investigate corticosterone (CORT) in serum and
FCM levels in faeces of laboratory mice, as quantified in four
different ELISA kits (DRG EIA-4164, Demeditec DEV9922,
Enzo ADI-900-097 and Cayman EIA kit 500655). Assay kits
were chosen based on the origin of the antibody, detection
level and variation in cross-reactivity. Results: As expected,
all four assay kits could detect higher serum CORT levels in
mice treated with adrenocorticotropic hormone (ACTH),
compared to untreated mice. Unexpectedly though, the
measured concentration of serum CORT differed significantly
between assays, in both groups of mice. In faecal samples,
there was no consistent positive correlation between the levels
detected in the four assays and the measured concentration of
FCM also differed between assays. Conclusion: Whereas
commercially available CORT ELISAs are frequently
successfully used for FCM quantification, validation of the
assays is necessary as all assays do not work well under all
circumstances. In this study, the ELISAs could determine
relative differences in serum CORT levels and FCM levels
between samples; however, the fidelity of the measurements to
the true concentrations was low.
Recognition and assessment of physiological stress is
essential in the care of, and experimentation on, laboratory
mice, since stress may have a considerable negative impact
on the welfare of animals, as well as on experimental data
(1). A common way of assessing stress is to measure the
concentration of corticosterone (CORT) in blood.
Corticosterone is increased in blood within a few minutes
during an acute stress response and, thus, measuring the
blood concentration of CORT is a well-validated method for
determining acute stress (2-7). However, a blood sample
gives only the momentary concentration and, therefore,
merely reflects the stress response at that very instant. The
blood sampling procedure itself is also problematic, since it
is invasive and requires certain form of restraint, which
causes stress and trauma to the animal (4, 5). To circumvent
these issues, faeces can be collected from the mouse cage
and faecal CORT metabolites (FCM) can be extracted. The
FCM levels reflect an average of the preceding CORT levels
in the blood during a chosen time period (8). Furthermore,
invasive procedures on the animals are avoided, since
collection of faecal pellets can be performed with minimal
or no interference. 
Many studies, among them certain performed in our
laboratory, have applied commercially available enzyme-
linked immunosorbent assays (ELISAs) for the
quantification of FCM for stress assessment in several
animal species, including laboratory mice (3-5, 9-12).
However, such assays are generally designed for measuring
serum CORT in its native form, with the content of native
CORT being very low in faecal samples (13). Thus, in
faeces, these assays mainly detect a panorama of
immunoreactive CORT metabolites, which in many cases
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accurately reflect the preceding levels of serum CORT (14-
16). However, since different assays utilise antibodies of
different origin and specificity, the detection level and cross-
reactivity towards different metabolites and other, unrelated,
steroids differ considerably between assays. Thus, the
validity of one assay for FCM quantification in stress
assessment is not necessarily the same for another assay.
In order to elucidate this matter, we designed the present
study to investigate CORT in serum and FCM levels in
faeces of laboratory mice, as quantified in four different
ELISA kits (DRG EIA-4164, Demeditec DEV9922, Enzo
ADI-900-097 and Cayman EIA kit 500655). Assay kits were
chosen based on the origin of antibody, reported detection
level and variation in cross-reactivity to different metabolites
and other steroids (see Table I for details). The DRG assay
has been extensively used and validated in our laboratory
(14, 15). Therefore, we used this assay as the reference assay
to compare the other assays with. 
The null hypothesis was that all four assays would detect
the same levels of serum CORT and FCM from each unique
sample. The aim of the study was to generate information
that can be useful in the interpretation of data from faecal
samples during stress assessment in laboratory mice. 
Materials and Methods
Animals. All animal housing and experimental protocols in the
present study were approved by the Danish Animal Experiments
Inspectorate (license no. 2012-DY-2934-00018) under the Ministry
of Environment and Food and after review of the local animal
welfare body of the faculty. The animal use was, thus, in accordance
to Danish legislation on experimental animals and to Directive
2010/63/EU on the Protection of Animals used for Scientific
Purposes. 
Twenty-four male outbred BomTac:NMRI mice from Taconic,
Ry, Denmark, were used in the study. 
Housing conditions. The animals were housed in an animal facility
fully accredited by the Association for the Assessment and
Accreditation of Laboratory Animal Care (AAALAC) in accordance
with the Guide for Care and Use of Laboratory Animals (17) and with
Directive 2010/63/EU (18). Before the experiments, the mice were
single-housed in individually ventilated Macrolone type III cages (800
cm2 floor area; 15 cm high) for one week prior to experimentation.
Wooden chips (Tapvei Oy., Kortteinen, Finland) were used as bedding
material. Bite bricks (Tapvet®, Kortteinen, Finland), Enviro-dri®
nesting materials (Shepherd Specialty papers, Quakertown, PA, USA)
and cardboard houses (Brogaarden, Gentofte, Denmark) were used
for environmental enrichment. A diurnal rhythm was maintained with
a 12:12 hour light-dark cycle, with artificial light from 06:00. Cage
temperature was kept at 22˚C, relative humidity at 50% and the air
was exchanged 75 times per h. Mice were fed ad libitum with
Altromin 1319 pellets (Brogaarden, Gentofte, Denmark) and acidified
tap water was available at all times.
Study design. Mice were divided into four groups with six mice in
each. Group size was based on a power analysis (19) where a two-
fold increase in mean FCM levels after adrenocorticotropic hormone
(ACTH) injection was considered biologically relevant, based on
previous studies (14-16). The standard deviation was estimated to
be approximately 0.75 times the mean, the level of significance (α)
was set to 5% and the desired power (1-β) was set to 80%.
At 9 a.m., mice in all groups were placed in a clean cage to
enable sampling of faecal pellets dropped after the experiment
started. Mice in Group 1 and 3 were left alone until the subsequent
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Table I. Overview of ELISAs applied in the study. 
Assay                                                               Antibody                                             Detection level                                Cross-reactivity (>0.1%)
                                                                                                                                                                                                                   
DRG EIA-4164                            Polyclonal (species unspecified)                   <1.6 nmol/l (553 pg/ml)                              Progesterone 7.4%
                                                                                                                                                                                             Deoxycorticosterone 3.4%
                                                                                                                                                                                         11-dehydrocorticosterone 1.6%
                                                                                                                                                                                                       Cortisol 0.3%
                                                                                                                                                                                                   Pregnenolone 0.3%
Demeditec DEV9922                               Rabbit polyclonal                                1.6 nmol/l (553 pg/ml)                      11-deoxycorticosterone 2.4%
                                                                                                                                                                                                   Progesterone 0.7%
                                                                                                                                                                                                       Cortisol 0.3%
                                                                                                                                                                                                    Aldosterone 0.2%
Enzo ADI-900-097                                   Sheep polyclonal                             26.99 pg/ml (0.078 nmol/l)                    Deoxycorticosterone 28,6%
                                                                                                                                                                                                   Progesterone 1.7%
                                                                                                                                                                                        Tetrahydrocorticosterone 0.28%
                                                                                                                                                                                                   Aldosterone 0.18%
                                                                                                                                                                                                   Testosterone 0.13%
Cayman EIA 500655                                Sheep polyclonal                               30 pg/ml (0.087 nmol/l)                      11-deoxycorticosterone 11%
                                                                                                                                                                                          11-dehydrocorticosterone 7%
                                                                                                                                                                                                  Progesterone 0.31%
                                                                                                                                                                                                      Cortisol 0.17%
Data are based on information reported by the manufacturers.
blood and faecal sampling. Mice in Group 3 and 4 were injected
subcutaneously with 2 mg/kg ACTH (ACTH 1-24; PolyPeptide
Laboratories, Strasbourg, France) in 0.25 ml PBS. At 11 a.m. (2 h
after start), blood and faeces were collected from mice in Group 1
and 2 and, at 17 p.m. (8 h after start), blood and faeces were
collected from mice in Group 3 and 4. 
Blood and faecal sampling. At the time of sampling, mice were
concussed and decapitated; blood was collected in Eppendorf tubes.
The procedure was completed within 30 seconds. Blood was left to
coagulate in a refrigerator for 45 min, followed by centrifugation
for 10 min, in order to obtain serum. Serum was stored at −20˚C
until analysis. After blood sampling, the bedding material from the
cage was collected, whereafter all faecal pellets in the cage were
gathered and analysed for faecal corticosteroid metabolites. 
Enzyme-linked immunosorbent assays (ELISAs). Four different
ELISA kits were used in the study. Each serum and faecal extract
sample was analysed in parallel in four different commercially
available ELISA kits, namely DRG EIA-4164 (DRG Diagnostics,
Marburg, Germany), Demeditec DEV9922 (Demeditec, Kiel-
Wellsee, Germany), Enzo ADI-900-097 (Enzo Life Sciences,
Plymoth meeting, PA, USA) and Cayman EIA kit 500655 (Cayman
Chemical Company, Ann Arbor, MI, USA), according to the
manufacturers’ instructions. Assays were chosen based on origin of
antibody (sheep or rabbit IgG), detection level (25-500 pg/ml) and
variation in cross-reactivity profile (see Table I for details).
Quantification of CORT and immunoreactive CORT metabolites.
Serum samples from each individual mouse were thawed and tested
for CORT concentration in all the four different ELISA kits, in
accordance with the manufacturers’ instructions. Faecal samples
were thawed and faecal CORT and FCM were extracted as
previously described (3, 14, 15). In brief, FCM were extracted by
incubating faeces in 96% ethanol overnight at a ratio of 5 ml
ethanol per gram faeces. The homogenate was centrifuged at 3,000
× g in a Labogene Scanspeed 1236R centrifuge (Labogen A/S,
Lynge, Denmark) for 20 min, the supernatant was decanted and the
pellet discarded. A 1-ml aliquot of the supernatant was further
centrifuged at 10,000 × g for 15 min in a table top centrifuge
(Eppendorf 5415D; Eppendorf AG, Hamburg, Germany). A volume
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Figure 1. Concentration of corticosterone (CORT) in serum samples (ng/ml) in non-treated and adrenocorticotropic hormone (ACTH)-treated mice
as quantified in the four ELISAs. Data are presented as individual data points for each animal and assay. A: 2 h and B: 8 h after intervention with
mice in the ACTH groups. 
Figure 2. Concentration of corticosterone (CORT) in serum samples
(ng/ml) detected by the DRG assay compared to the concentration in
the other three assays. Data are presented as individual data points for
each animal and assay. Coloured lines represent the linear regression. 
of 200 μl of the supernatant was recovered with a pipette while
carefully avoiding aspirating any pelleted material and evaporated
in a Genevac EZ-2 evaporator (Genevac Ltd., Ipswich, UK). The
crystalized material was re-suspended in 200 μl assay buffer and
analysed as described above. 
Statistical analysis. All graphs and statistical calculations were
performed in GraphPad Prism 5.0 (GraphPad Inc. La Jolla, CA,
USA). Serum CORT concentrations (ng/ml) and FCM levels
(excreted ng/h) were log-transformed and compared with a two-way
analysis of variance (ANOVA) with Bonferroni’s post-hoc test.
Treatment and assay were set as variables. Furthermore, linear
regression was performed for all values obtained in the Demeditec,
Enzo and Cayman assays in relation to the DRG assay. 
Results
Serum CORT. The serum CORT concentrations detected in the
four assays are shown in Figure 1. All four assays could detect
significantly higher serum CORT levels in mice treated with
ACTH, compared to untreated mice, 2h after intervention
(p<0.001), as determined with a two-way ANOVA with
Bonferroni’s post-hoc test. The same test also showed that the
measured concentration of serum CORT differed significantly
between assays (p<0.0001), for both groups of mice. 
The serum CORT levels detected in the DRG assay were
compared to the levels in the three other assays using linear
regressions (Figure 2). All three assays were positively
correlated with the DRG kit where the Demeditec assay had
a slope of 1.21±0.21, which was significantly different from
0 (p<0.0001), and the goodness of fit (r2) was 0.64. The
Enzo assay had a slope of 2.02±0.25 (p<0.0001) and an r2
of 0.74. The Cayman assay had a slope of 1.22±0.1251
(p<0.0001) and an r2 of 0.83.
in vivo 30: 739-744 (2016)
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Figure 3. Levels of immunoreactive faecal corticosterone metabolites (FCM) in faecal samples (expressed as ng excreted per h) in non-treated and
adrenocorticotropic hormone (ACTH)-treated mice as quantified in the four ELISAs. Data are presented as individual data points for each animal
and assay. A: 2 h and B: 8 h after intervention with mice in the ACTH groups. 
Figure 4. Levels of immunoreactive faecal corticosterone metabolites
(FCM) in faecal samples (expressed as ng excreted per h) detected by
the DRG assay compared to the concentration in the other three assays.
Data are presented as individual data points for each animal and assay.
Coloured lines represent the linear regression. 
Faecal CORT metabolites. The FCM levels detected in the four
assays are shown in Figure 3. There was no significant effect
of the ACTH treatment on the FCM levels. However, similar
to the serum concentrations, there was a significant difference
in FCM between the four assays, as determined with the two-
way ANOVA (p<0.0001), in both groups of mice. 
The FCM levels detected in the DRG assay was compared
to the levels in the three other assays with linear regression
(Figure 4). Here, all assays, except for Cayman, were
positively correlated with the DRG kit. The Demeditec assay
had a slope of 0.68±0.18 (significantly different from 0;
p<0.005) and a goodness of fit (r2) of 0.40. The Enzo assay
had a slope of 0.81±0.07 (p<0.0001) and an r2 of 0.84. The
Cayman assay had a slope of –0.12±0.21 (not significantly
different from 0; p=0.59) and an r2 of 0.01.
Discussion
The present study investigated the suitability of using different
commercially available ELISA kits for quantifying the levels
of FCM in relation to the levels of CORT detected in serum. 
As expected, all four assays could detect higher serum
CORT levels in mice treated with ACTH, compared to
untreated mice. Furthermore, a higher level of serum CORT
in non-ACTH-treated mice was seen in the evening (8 h after
intervention), which follows the natural circadian rhythm of
mice (20, 21). Unexpectedly though, the measured
concentration of serum CORT differed significantly between
assays, for both groups of mice. On the other hand, in all
assays the relative difference between treated and non-treated
mice followed the same pattern; all assays were positively
correlated with the DRG assay. This means that the CORT
assays tested in this study are, as expected, fully applicable
in order to distinguish between high and low levels of serum
CORT. However, caution must be taken when discussing
absolute concentrations of CORT, since the ELISAs appear
to deviate from the true serum values by some margin. 
In faecal samples, similar to serum samples, the actual
concentration of FCM measured also differed unexpectedly
between assays. It was expected that the FCM values would
be higher 8 hours after ACTH injection, since this is the
approximate lag time (16, 22, 23) from adrenal release to
subsequent excretion in faeces of CORT for rats and mice.
However, in a recent study from our laboratory, we discovered
that a single injection of 2 mg/kg ACTH, which was used in
the present study, is not sufficient to induce a satisfactory
increase in blood CORT that causes a significantly elevated
FCM level in faeces but that repeated injections of this dose
are necessary (15). Thus, we were unable to confirm that
elevated serum levels of CORT actually do lead to elevated
levels in FCM in the present study. However, this was not the
main scope of the present study and, since we have previously
presented evidence of the applicability of FCM (15), we chose
not to proceed with this matter. As expected though, lower
levels were observed in non-ACTH-treated mice in the
evening (8 h after intervention). This was expected since the
FCM rhythm is inverted compared to serum levels, following
the lag time discussed above.
Commercially available immunoassays may be
problematic for FCM quantification, since they detect
immunoreactive CORT metabolites in faeces, and the precise
composition of metabolites in faeces is rarely known and is
likely to vary between sex and between strains of mice, as
well as between different experimental conditions. Therefore,
other approaches have been suggested for quantifying FCM
in an appropriate manner. It has, for instance, been suggested
that the CORT metabolite 5α-pregnane-3β,11β,21-triol-20-
one measured in faeces is predictive of preceding serum
CORT levels in mice (13, 24). However, the assay for 5α-
pregnane-3β,11β,21-triol-20-one is not commercially
available and, thus, needs to be set up in the laboratory.
Since other studies have demonstrated that quantification of
a number of immunoreactive metabolites is indeed
representative of preceding CORT levels both in rats and
mice, this method should be considered just as reliable,
provided that it is properly validated. The results presented
in this study illustrate the importance of assay validation
when using FCM for investigating adrenocortical activity in
mice and that all assays applied need to be validated before
any interpretation can be done, regardless of whether a set
of immunoreactive CORT metabolites or a specific
metabolite is being used. 
In conclusion, commercially available corticosterone
ELISAs are useful for FCM quantification in most cases;
however, validation of an assay is necessary before it can be
applied in stress assessment. Furthermore, the ELISA can
accurately determine relative differences in serum CORT and
FCM levels between samples but the precision in
determining the actual value of the concentration is low.
Acknowledgements
The Authors wish to thank Trine Marie Ahlman Glahder and Helle
Porsdal for their invaluable technical assistance. 
References 
1 Morton DB and Hau J: Welfare assessment and humane
endpoints. In: Handbook of Laboratory Animal Science: Volume
1 - Essential Principles and Practices (Hau J, Schapiro SJ eds.).
Boca Raton: CRC Press, pp. 535-572, 2011.
2 Azpiroz A, Fano E, Garmendia L, Arregi A, Cacho R, Beitia G
and Brain PF: Effects of chronic mild stress (CMS) and
imipramine administration, on spleen mononuclear cell
proliferative response, serum corticosterone level and brain
norepinephrine content in male mice. Psychoneuroendocrinol 24:
345-361, 1999.
Abelson et al: Commercially Available ELISAs and Faecal Corticosterone Metabolites
743
3 Sundbom R, Jacobsen KR, Kalliokoski O, Hau J and Abelson
KS: Post-operative corticosterone levels in plasma and feces of
mice subjected to permanent catheterization and automated
blood sampling. In Vivo 25: 335-342, 2011.
4 Teilmann AC, Kalliokoski O, Sorensen DB, Hau J and Abelson
KS: Manual versus automated blood sampling: impact of
repeated blood sampling on stress parameters and behavior in
male NMRI mice. Lab Anim 48: 278-291, 2014.
5 Teilmann AC, Nygaard MA, Holst B, Hau J, Rozell B and
Abelson KS: Physiological and pathological impact of blood
sampling by retro-bulbar sinus puncture and facial vein
phlebotomy in laboratory mice. PLoS One 9: e113225, 2014.
6 Tuli JS, Smith JA and Morton DB: Effects of acute and chronic
restraint on the adrenal gland weight and serum corticosterone
concentration of mice and their faecal output of oocysts after
infection with Eimeria apionodes. Res Vet Sci 59: 82-86, 1995.
7 Woodman DD: The adrenal glands. In: Laboratory Animal
Endocrinology: Hormonal Action, Control Mechanism and
Interactions with Drugs. Chichester: John Wiley and Sons Ltd.,
pp. 253-286, 1997.
8 Goymann W: Noninvasive monitoring of hormones in bird
droppings: physiological validation, sampling, extraction, sex
differences, and the influence of diet on hormone metabolite
levels. Ann NY Acad Sci 1046: 35-53, 2005.
9 Jacobsen KR, Fauerby N, Raida Z, Kalliokoski O, Hau J,
Johansen FF and Abelson KS: Effects of buprenorphine and
meloxicam analgesia on induced cerebral ischemia in C57BL/6
male mice. Comp Med 63: 105-113, 2013.
10 Jacobsen KR, Kalliokoski O, Teilmann AC, Hau J and Abelson
KS: The effect of isoflurane anaesthesia and vasectomy on
circulating corticosterone and ACTH in BALB/c mice. Gen
Comp Endocrinol 179: 406-413, 2012.
11 Teilmann AC, Jacobsen KR, Kalliokoski O, Hansen AK, Hau J
and Abelson KS: The effect of automated blood sampling on
corticosterone levels, body weight and daily food intake in
permanently catheterized male BALB/c mice. In Vivo 26: 577-
582, 2012.
12 Teilmann AC, Kalliokoski O, Jacobsen KR, Hau J and Abelson
KS: Impact of heparin and short term anesthesia on the
quantification of cytokines in laboratory mouse plasma. Acta Vet
Scand 56: 33, 2014.
13 Touma C, Sachser N, Mostl E and Palme R: Effects of sex and
time of day on metabolism and excretion of corticosterone in
urine and feces of mice. Gen Comp Endocrinol 130: 267-278,
2003.
14 Kalliokoski O, Jacobsen KR, Teilmann AC, Hau J and Abelson
KS: Quantitative effects of diet on fecal corticosterone
metabolites in two strains of laboratory mice. In Vivo 26: 213-
221, 2012.
15 Kalliokoski O, Teilmann AC, Abelson KS and Hau J: The
distorting effect of varying diets on fecal glucocorticoid
measurements as indicators of stress: a cautionary demonstration
using laboratory mice. Gen Comp Endocrinol 211: 147-153,
2015.
16 Siswanto H, Hau J, Carlsson HE, Goldkuhl R and Abelson KSP:
Corticosterone concentrations in blood and excretion in faeces
after ACTH administration in male Sprague-Dawley rats. In
Vivo 22: 435-440, 2008.
17 Institute of Laboratory Animal Research: Guide for the Care and
Use of Laboratory Animals. Washington DC: The National
Academies Press, 2011.
18 Directive 2010/63 of the European Parliament and of the
Council of 22 September 2010 on the protection of animals used
for scientific purposes. Official Journal of the European Union
L246: 33-77, 2010.
19 Festing MFW and Weigler BJ: Experimental design and
statistical analysis. In: Handbook of laboratory animal science,
vol. 1. Essential principles and practices (Hau J, van Hoosier Jr.
GL eds.). Boca Raton: CRC Press, pp. 327-350, 2003.
20 Barriga C, Martin MI, Tabla R, Ortega E and Rodriguez AB:
Circadian rhythm of melatonin, corticosterone and phagocytosis:
effect of stress. J Pineal Res 30: 180-187, 2001.
21 Kannan Y: Neuroendocrine-immune network in stress. In:
Handbook of Experimental Animals - The Laboratory Mouse
(Hedrich HJ, Bullock G eds.). London: Elsevier, pp. 301-307,
2004.
22 Kalliokoski O, Hau J, Jacobsen KR, Schumacher-Petersen C and
Abelson KS: Distribution and time course of corticosterone
excretion in faeces and urine of female mice with varying
systemic concentrations. Gen Comp Endocrinol 168: 450-454,
2010.
23 Thanos PK, Cavigelli SA, Michaelides M, Olvet DM, Patel U,
Diep MN and Volkow ND: A non-invasive method for detecting
the metabolic stress response in rodents: Characterization and
disruption of the circadian corticosterone rhythm. Physiol Res
58: 219-228, 2009.
24 Touma C, Palme R and Sachser N: Analyzing corticosterone
metabolites in fecal samples of mice: a noninvasive technique to
monitor stress hormones. Hormones and Behavior 45: 10-22,
2004.
Received July 12, 2016
Revised July 19, 2016
Accepted July 20, 2016
in vivo 30: 739-744 (2016)
744
